1. HBW Insight
  2. >>Geography
  3. >>Europe

European Commission Must Decide If ‘Traditional Use’ Can Break Botanicals Deadlock

 
• By David Ridley

Allowing evidence for “traditional use” could break the regulatory deadlock regarding health claims made for botanical food supplements, the European Commission has suggested. This would unlock innovation currently stunted by the “on hold” situation, note researchers Alie de Boer and Karin Lenssen in a paper for the European Parliamentary Research Services (EPRS). However, there are regulatory issues that would need to be resolved for this to work, they point out.

It’s time to decide whether evidence of “traditional use” for botanical ingredients can be used to substantiate health claims made for food in the European Union, argues a report recently published by the European Parliament.

Otherwise, the uncertainty produced by the current regulatory situation, in which over 2,000 botanical health claims are “on hold” while the European Commission decides what to do, will continue to dampen innovation in the region, say Alie de Boer and Karin

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

US Tariffs Pose ‘Existential Threat’ To EU Medical Devices Industry

 
• By David Ridley

AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.

OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By David Ridley

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By David Ridley

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.